Search
Monte Rosa Therapeutics Inc
GLUEAdd to Watchlist
18.310USD
-0.100-0.54%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.54BMarket Cap
LossP/E TTM
Monte Rosa Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Monte Rosa Therapeutics Inc is 7.26, ranking 245 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -12.36, which is -744.06% below the recent high of 79.61 and -265.02% above the recent low of -45.12.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
